Infective Endocarditis: Experience of the Cardiology Department of the Mohammed VI University Hospital
Cardiology and Angiology: An International Journal, Volume 12, Issue 3,
Page 46-56
DOI:
10.9734/ca/2023/v12i3323
Abstract
Introduction: Infective endocarditis (IE) is a rare but potentially serious disease. It causes a high mortality and a high level of morbidity and complications. Its epidemiological, clinical and microbiological characteristics have changed in recent years.
The Aim of our Work: Is to study the epidemiological, clinical, bacteriological, ultrasonographic, therapeutic and evolutionary data of IE between January 2017 and October 2022 in the Mohammed VI University Hospital and to compare them to the global profile.
Materials and Methods: Retrospective study including 110 patients hospitalized for a definite IE, according to the modified DUKE criteria, in the cardiology department of the Mohammed VI University Hospital over a period of 5 years and 10 months from January 2017 to October 2022.
Results: The average age of our patients was 43 years with a male predominance. The bacterial graft was on native valve in 80% with predominance of rheumatic origin (69%), on cardiac prosthesis in 10% of patients, on healthy heart (4%) and congenital heart disease (6%). The most frequent portal of entry was dental (30%). Blood cultures were positive only in 33% of patients, isolating a staphylococcus (16%), a streptococcus (14%) and a GNB (3%). Transthoracic echocardiography (TTE) showed vegetation in 108 cases, valve perforation in 7 cases, cord rupture in 1 patient and perivalvular abscess in 10 cases. Seventy-seven percent of patients had surgical treatment with a mean delay of 29 days. The overall mortality was 24% with heart failure (p<0.001), renal failure (p=0.004) and neurological complications (p=0.002) as predictive factors of mortality.
Conclusion: Infective endocarditis remains a real health problem with a consequent mortality and morbidity. The population is often young, revealing the IE by complications; its prevention is the best way to improve its prognosis.
- Infective endocarditis
- entry portal
- echocardiography
- blood culture
- complications
- surgery
- prognosis
How to Cite
References
Delahaye F, Delahaye C. Endocardite infectieuse. EMC - Cardiologie 2023;37 (1):1-16 [Article 11-013-B-10].
Harrak S, Doghmi N, Fellat B, Zarzur J, Cherti M.L’endocardite infectieuse au Maroc à travers l’expérience d’un service hospitalier.Annales de Cardiologie et d’Angéiologie. 2019;68:87–93.
Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis – Prospective Cohort study. Arch Intern Med. 2009;169:463–73.
Wang A. The changing epidemiology of infective endocarditis: The paradox of prophylaxis in the current and future eras. J Am Coll Cardiol 2012 May 29;59(22):1977–8.
Revest M, Doco-Lecompte T, Hoen B, Alla F, Selton-Suty C, Duval X.Épidémiologie de l’endocardite infectieuse en France. Bulletin épidémiologique hebdomadaire. 2 avril 2013 / n° 10.
Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endo-carditis: results of a1-year survey in France. JAMA. 2002;288:75–81.
Duval X, Hoen B. Evolution du profil épidémiologique des endocarditesinfectieuses. J Anti Inf 2011; 13:155–60.
Hammami K, Kammoun S, Benjemaa M. 10emes journées médico-chirurgicales de Sfax compte rendu de la table ronde « l’endocardite infectieuse ≫. Rev Tun infectiol. 2007;1:32-4.
Mzoughi K, Zairi I, Jabeur M, Ben Moussa F, Kamoun S, Ben Said R, Souabni I, Fennira S, Kraiem S.Etude descriptive de l’endocardite infectieuse: Données du Service de Cardiologie de l’Hôpital Habib Thameur. Cardiologie Tunisienne - Volume 10 N°03 - 3 185 eTrimestre 2014 ;185-190.
Letaief A, Boughzala E, Kaabia N, et al. Epidemiology of infective endo-carditis in Tunisia: A 10-year multicenter retrospective studying. Int J Infect Dis 2007;11:430–3.
Benatta NF, et al. Endocardite infectieuse: Expérience du service de cardiologie de l’établissement hospitalo-universitaire Oran. Ann Cardiol Angeiol (Paris) (2018).
Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl JMed. 2001;345:1318–30.
Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristicsand the effect on mortality in endocarditis. Arch Intern Med 2002;162:90–4.
Capilla E, et al. Endocardite infectieuse : caractéristiques cliniques et pronostic entre 2004 et 2014 dans un hôpital non universitaire. Ann Cardiol Angeiol Paris; 2016.
Goulet V, Etienne J, Fleurette J, Netter R. L’endocardite infectieuse en France. Caractéristiques épidémiologiques. Presse Med. 1986;15(37):1855–8.
Tleyjeh iM, Abdel-Latif A, Rahbi H et al. A systematic review of population -based studies of infective endocarditis. Chest. 2007;132:1025-35.
Fowler Jr VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012–21.
Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Press-man GS, et al. Infective endocarditis epidemiology over five decades: Asystematic review. PLoS One. 2013;8(12):e82665.
Hannachi n. Les endocardites infectieuses. Thèse de doctorat en médecine. Faculté de médecine de Tunis; 1979.
Delahaye F, goulet V, Lacassin F. Characteristics of infective endocarditis in France in 1991. A 1-Year surgery. Eur Heart J. 1995;16 :394-401.
Netzer R, Zollinger E, Seiler C, Cerny A. Infective endocarditis: clinical spectrum, presentation and outcome, analysis of 212 cases. Heart. 2000;3:184–96.
Parize P, Mainardi JL. Les actualités dans l’endocardite infectieuse. Rev Med Int. 2010:612-21.
Lagier JC, Letranchant L, Selton-study C, n loga J, Aissa n, Alauzet C et al. Bactériémies et endocardites à staphylococcus aureus. Ann Cardiol Angeiol. 2008;57:71-7.
Que Y-A, oddo M, Liaudet i, Moreillon P. Endocardites infectieuses : mise au point. Rev Med Suisse Romande. 2004;124:341-6.
Habib G, Lancellotti P, Antunes MJ, et al. ESC Guidelines for the management of infective endocarditis. The task force for the management ofinfective endocarditis of the European Society of Cardiology (ESC). EurHeart J. 2015;36:3075–128.
Perez de isla L, Zamorano J, Lennie V, Vazquez J, Ribera JM, Macaya C. negative blood culture infective endocarditis in the eldery: long-term follow-up. gerontol. 2007;53 :245-9.
Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis,and treatment of infective endocarditis (new version 2009). The Task Forceon the Prevention, Diagnosis, and Treatment of Infective Endocarditis ofthe European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369–413.
Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, IungB, et al. Preeminence of Staphylococcus aureus in infective endocarditis: A 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9.
Trabelsi I, Rekik S, Znazen A, et al. Native valve infective endocarditisin a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102:1247–51.
Loire R, Tabib A. L’endocardite infectieuse mortelle aspects anatomiques actuels. A propos de 63 observations. Sem Hop Paris. 1985;62:2463-6.
Heiro M, nikoskelainen J, Engblom E, et al. neurologic manifestations of infective endocarditis: A 17-year experience in a teaching hospital in Finland. Arch intern Med 2000; 160:2781-7.
Corral I, Martin-davila P, Fortun J, et al. Trends in neurological complications of endocarditis. J Neurol. 2007;254:1253-9.
Tornos P, Gonzalez T, Thuny F, Habib G. Infective endocarditis: The European viewer point. Curr Probl Cardiol 2011; 36:175–222.
Mouly S, Ruimy R, Launay O et al. The changing clinical aspects of infective endocarditis: Descriptive review of 90 episodes in a French teachinghospital and risk factors of death. J infect 2002;45: 246–56.
Remadi JP, Habib G, Nadji G, Brahim A, Thuny F, Casalta JP, et al. Pre-dictors of death and impact of surgery in Staphylococcus aureus in fectiveendocarditis. Ann Thorac Surg 2007;83:1295–302.
Duval X, Delaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications. Am J Cardiol. 2012;59 (22):1968–76.
-
Abstract View: 20 times
PDF Download: 23 times
